OptiBiotix Health Plc
OPBXF
Other OTC0.22
USD
- -
- -
Return %
Stock
S&P500
1Y
- -
26.84
3Y
- -
77.03
5Y
- -
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Stephen Patrick O'Hara
- Full Time Employees
- 9
- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- Innovation Centre York United Kingdom YO10 5DG
- IPO Date
- Oct 19, 2015
- Website
- optibiotix.com
- Similar Companies
- Business
- OptiBiotix Health Plc is a life sciences company specializing in developing and commercializing novel health and wellness ingredients to address obesity, diabetes, and cardiovascular health. The company’s core products include patented probiotics, prebiotics, and nutraceutical ingredients marketed under brands such as SlimBiome, SlimMax, SlimGut, and OptiClean, targeted primarily at weight management, blood sugar regulation, and cholesterol control. OptiBiotix develops functional food ingredients and supplements designed for incorporation into consumer health products and operates globally with a focus on the UK, Europe, and the US markets. Founded in 2005, the company is headquartered in Manchester, United Kingdom. Recent strategic developments include launching new product offerings focused on modulating the microbiome for metabolic health and forming partnerships to expand its commercial reach and manufacturing capabilities. OptiBiotix has also progressed in clinical validation of its products and expanded its ingredient portfolio through research collaborations. These moves align with its strategic shift towards becoming a leading provider of scientifically supported probiotic and nutraceutical solutions to both consumer and pharmaceutical sectors. The company actively pursues growth through product innovation, licensing deals, and geographical market expansion. OptiBiotix operates within the nutraceuticals and functional food ingredient industry segments, targeting consumers concerned with metabolic health issues such as obesity, diabetes, and cardiovascular disease. Its customers include food and beverage manufacturers, supplement producers, and pharmaceutical companies seeking scientifically backed health ingredients. The company’s operational and commercial activities span research and development, ingredient manufacturing, marketing, and global distribution. Its direct subsidiaries and strategic alliances support product development and market penetration initiatives on a global scale. This comprehensive focus on microbiome modulation for metabolic health, underpinned by patented probiotics and prebiotic formulations, positions OptiBiotix as a specialized innovator within the health sciences space. Its ongoing clinical and commercial advances reinforce its commitment to providing scientifically validated health solutions with a global footprint.
OptiBiotix shares up on weight-management order